MSC
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
The Children's Hospital of Zhejiang University School of Medicine
Overview
MSC is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MSC clinical trials
Explore related
Medical disclaimer. This page summarizes research about MSC for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.